Video

Dr. Garon on Unique Challenges of COVID-19 in Lung Cancer

Author(s):

Edward B. Garon, MD

In Partnership With:

Edward B. Garon, MD, discusses unique challenges of the coronavirus disease 2019 in lung cancer.

Edward B. Garon, MD, director of Thoracic Oncology at the Jonsson Comprehensive Cancer Center at University of California, Los Angeles, discusses unique challenges of the coronavirus disease 2019 (COVID-19) in lung cancer.

According to Garon, patients at UCLA did not appear to be dramatically hindered by COVID-19 exposure, which suggests they took necessary safety precautions.

However, patients with lung cancer are faced with unique challenges regarding COVID-19 as many of the symptoms associated with the virus, such as cough and fever, are also symptoms of lung cancer, Garon explains.

As such, it is necessary to ensure that health care professionals are comfortable when meeting with patients at clinics, as patients with lung cancer who may be coming in could have chronic cough or fever at baseline, but not be positive for COVID-19, concludes Garon.

Related Videos
Howard S. Hochster, MD, FACP,
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Michael R. Grunwald, MD, FACP
Peter Forsyth, MD
John N. Allan, MD
Dr Dorritie on the Clinical Implications of the 5-Year Follow-Up Data From CAPTIVATE in CLL/SLL
Minoo Battiwalla, MD, MS
Related Content
Aditya Bardia, MD, MPH, FASCO, of UCLA
October 15th 2024

TROP2 Offers Attractive Therapeutic Target in Breast Cancer and Other Solid Tumors

Aaron Lisberg, MD, assistant clinical professor, medicine, University of California, Los Angeles School of Medicine
August 1st 2024

Lisberg Lends Insight About the TROPION-Lung01 Trial of Dato-DXd in NSCLC

Adam E. Singer, MD, PhD, of UCLA Health
September 13th 2024

Cabozantinib/Nivolumab Combination Findings Further Inform RCC Care

Stephanie L. Graff, MD, director, Breast Oncology, Lifespan Cancer Institute, associate professor, medicine, Brown University; Reshma L. Mahtani, DO, medical oncologist, Miami Cancer Institute, chief, Breast Medical Oncology, Baptist Health’s Wellness and Medical Complex; Kelly E. McCann, MD, PhD, breast medical oncologist, assistant clinical professor, medicine, the University of California, Los Angeles Health David Geffen School of Medicine; Hope S. Rugo, MD, Winterhof Family Endowed Professor in Breast Cancer, the University of California San Francisco (UCSF), professor, medicine, Division of Hematology and Oncology, director, Breast Oncology, director, Clinical Trials Education, director, Cancer Infusion Services, the UCSF Helen Diller Family Comprehensive Cancer Center
April 11th 2024

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology

Adam E. Singer, MD, PhD, of UCLA Health
September 12th 2024

Histologic Features, Risk Help Reduce Uncertainties Around Frontline Treatment Selection in RCC

Ritu Salani, MD, director, Gynecologic Oncology, University of California Los Angeles
August 28th 2024

Novel Targets Facilitate Treatment Advances and Spur Further Questions in Endometrial Cancer